| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
run for pharmaceutical analysts by pharmaceutical analysts
| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
NEXT EVENT: Thursday 7th February 2019 - Accelerated development and approval... 
JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
LAST EVENT:
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
Thursday 7th February 2019
Accelerated development and approval
Royal Society of Chemistry, London
This symposium offers a diverse programme of talks to look at many facets of drug development programmes, and how analytical science can assist, or is impacted by, the desire to reduce the time taken to get a product to market.
Acceleration of drug development programmes is a common theme whether for smaller companies, or for the larger bio-pharmaceutical players. Reduced time for product development can lead to reduced process experience, fewer clinical batches and increasing the numbers of dependent activities that are run in parallel. Each of these factors may impact analytical scientists, whether in reduced time to develop methods and specifications, limited real-time product stability data, or in increased volume of samples that are generated in short periods of time.
Speakers:
Neil Clayton - Pfizer
Dr Paul Newby - GlaxoSmithKline
Dr Daniel OConnor - MHRA
Henk Poelman - PRA Health Sciences
Dr Matt Popkin - GlaxoSmithKline
Dr Przemek Stasica - GlaxoSmithKline
Dr Andrew Teasdale - AstraZeneca
DETAILS AND REGISTRATION
Accelerated development and approval
Royal Society of Chemistry, London
This symposium offers a diverse programme of talks to look at many facets of drug development programmes, and how analytical science can assist, or is impacted by, the desire to reduce the time taken to get a product to market.
Acceleration of drug development programmes is a common theme whether for smaller companies, or for the larger bio-pharmaceutical players. Reduced time for product development can lead to reduced process experience, fewer clinical batches and increasing the numbers of dependent activities that are run in parallel. Each of these factors may impact analytical scientists, whether in reduced time to develop methods and specifications, limited real-time product stability data, or in increased volume of samples that are generated in short periods of time.
Speakers:
Neil Clayton - Pfizer
Dr Paul Newby - GlaxoSmithKline
Dr Daniel OConnor - MHRA
Henk Poelman - PRA Health Sciences
Dr Matt Popkin - GlaxoSmithKline
Dr Przemek Stasica - GlaxoSmithKline
Dr Andrew Teasdale - AstraZeneca
DETAILS AND REGISTRATION
COLLABORATIVE EVENT: Friday 8th February 2019
RPS Science & Research Summit
ETC.VENUES COUNTY HALL, LONDON
In collaboration with the Royal Pharmaceutical Society and the Academy of Pharmaceutical Sciences
Chaired by RPS Chief Scientist Gino Martini and featuring keynote speakers Dame Sally Davies and Professor Molly Stevens, the Science and Research Summit will showcase the latest ground-breaking developments in pharmacy, research and pharmaceutical sciences and debate some of the most pressing challenges and opportunities for the future of healthcare.
DETAILS AND REGISTRATION
RPS Science & Research Summit
ETC.VENUES COUNTY HALL, LONDON
In collaboration with the Royal Pharmaceutical Society and the Academy of Pharmaceutical Sciences
Chaired by RPS Chief Scientist Gino Martini and featuring keynote speakers Dame Sally Davies and Professor Molly Stevens, the Science and Research Summit will showcase the latest ground-breaking developments in pharmacy, research and pharmaceutical sciences and debate some of the most pressing challenges and opportunities for the future of healthcare.
DETAILS AND REGISTRATION
Thursday 21st March 2019
Stability IV: Developments in stability testing and evaluation
Royal Society of Chemistry, London
Continuing our successful series of stability meetings, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for evaluating data and predicting stability
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors
Speakers:
Dr Jonathan Bright - AstraZeneca
John Cleverley - Clarivate Analytics
Dr Paul Fullerton - AMRI
Conor Jamieson - Sandwell and West Birmingham NHS Trust
Dr Rachel Orr - GSK
Dr Garry Scrivens - Pfizer
Susan Smith - AstraZeneca
Dr Maria Krisch - Freethink Technologies Inc
DETAILS AND REGISTRATION
Stability IV: Developments in stability testing and evaluation
Royal Society of Chemistry, London
Continuing our successful series of stability meetings, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for evaluating data and predicting stability
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors
Speakers:
Dr Jonathan Bright - AstraZeneca
John Cleverley - Clarivate Analytics
Dr Paul Fullerton - AMRI
Conor Jamieson - Sandwell and West Birmingham NHS Trust
Dr Rachel Orr - GSK
Dr Garry Scrivens - Pfizer
Susan Smith - AstraZeneca
Dr Maria Krisch - Freethink Technologies Inc
DETAILS AND REGISTRATION
Thursday 21st March 2019
Annual General Meeting
Royal Society of Chemistry, London
This is a closed meeting for members of JPAG
It is not necessary to register for the symposium to attend the AGM
Starts at 9.30 am
DETAILS AND REGISTRATION
Annual General Meeting
Royal Society of Chemistry, London
This is a closed meeting for members of JPAG
It is not necessary to register for the symposium to attend the AGM
Starts at 9.30 am
DETAILS AND REGISTRATION
LAST EVENT:
Thursday 6th December 2018
Regulatory Hot Topics III
Royal Society of Chemistry, London
This one-day symposium will address issues and challenges associated with the implementation of new and emerging guidelines. It will provide an excellent opportunity for dialogue, discussion and debate with speakers - several of whom have been very actively involved in shaping the guidance - and the peer group in an open forum.
Delegates will be able to understand, interpret and translate into day-to-day practice the guidance on topics including elemental impurities, life-cycle management, DNA reactive (mutagenic) impurities, BCS-based biowavers, impurities in New Duug Substances, and the effect of MAPPS.
An excellent opportunity to learn from expert speakers involved in the development of the guidances on these key topics.
DETAILS
Regulatory Hot Topics III
Royal Society of Chemistry, London
This one-day symposium will address issues and challenges associated with the implementation of new and emerging guidelines. It will provide an excellent opportunity for dialogue, discussion and debate with speakers - several of whom have been very actively involved in shaping the guidance - and the peer group in an open forum.
Delegates will be able to understand, interpret and translate into day-to-day practice the guidance on topics including elemental impurities, life-cycle management, DNA reactive (mutagenic) impurities, BCS-based biowavers, impurities in New Duug Substances, and the effect of MAPPS.
An excellent opportunity to learn from expert speakers involved in the development of the guidances on these key topics.
DETAILS
Our only sponsors are our parent professional bodies:
Delegates of any JPAG symposia can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical Review
JPAG members can receive a free hard copy subscription to EPR
click here
JPAG members can receive a free hard copy subscription to EPR
click here
TESTIMONIALS:
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
LATEST NEWS:
THE GEOFFREY PHILLIPS ANALYTICAL SCIENCE AWARD 2018
It has been another successful year for the pharmaceutical analysis research awards and careers symposium held at the Royal Society of Chemistry on Tuesday 20th November 2018. Over 100 delegates attended the meeting with two highly inspirational keyn...
More...
Thursday 22nd November 2018
It has been another successful year for the pharmaceutical analysis research awards and careers symposium held at the Royal Society of Chemistry on Tuesday 20th November 2018. Over 100 delegates attended the meeting with two highly inspirational keyn...
More...
Thursday 22nd November 2018
Consultation on ICH M9 Step 2
The ICH guideline on Biopharmaceutics classification system-based biowaivers, ICH M9 is currently at step 2 (June 2018) and under public consultation.
Following JPAG's successful symposium on the ICH M9 topic (June 28th), JPAG are looking fo...
More...
Tuesday 3rd July 2018
The ICH guideline on Biopharmaceutics classification system-based biowaivers, ICH M9 is currently at step 2 (June 2018) and under public consultation.
Following JPAG's successful symposium on the ICH M9 topic (June 28th), JPAG are looking fo...
More...
Tuesday 3rd July 2018
Postgraduate student bursaries
Are you a postgraduate researcher in pharmaceutical or chemical analysis?
If so, did you know that you can now apply for a bursary which provides complimentary registration and assistance with travel costs to attend a JPAG meetin...
More...
Tuesday 5th December 2017
Are you a postgraduate researcher in pharmaceutical or chemical analysis?
If so, did you know that you can now apply for a bursary which provides complimentary registration and assistance with travel costs to attend a JPAG meetin...
More...
Tuesday 5th December 2017
COOKIES AND PERSONAL DATA:
This site does not use cookies.
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).
Follow us:
| Call us: | CONTACT US | Follow us: | | Terms and Conditions Privacy Statement |
| © Joint Pharmaceutical Analysis Group 2019 Website by Delta Consultancy Services |
|